SFX by Ex Libris Inc.

Title:	Structural basis of inhibitor selectivity in MAP kinases
Source:	Structure [0969-2126] Wang, Zhulun yr:1998

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Bellon, S. "The structure of phosphorylated p38gamma is monomeric and reveals a conserved activation-loop conformation." Structure 7.9 (1999): 1057-1065.
description	2.	Gallagher, Timothy F. "Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase." Bioorganic & medicinal chemistry 5.1 (1997): 49-64.
description	3.	Wilson, K P P. "The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase." Chemistry & biology 4.6 (1997): 423-31.
description	4.	Zhu, X. "Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors." Structure 7.6 (1999): 651-61.
description	5.	Guan, H. "Design and synthesis of aminopropyl tetrahydroindole-based indolin-2-ones as selective and potent inhibitors of Src and Yes tyrosine kinase." Bioorganic & medicinal chemistry letters 14.1 (2004): 187-2413.
description	6.	Koeberle, S. "Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor." Nature chemical biology 8.2 (2011): 141-3.
description	7.	Dale, Trevor C C. "Identification of the Axin and Frat binding region of glycogen synthase kinase-3." The Journal of biological chemistry 277.3 (2001): 2176-85.
description	8.	Pippel, Daniel J. "Reactions between Weinreb Amides and 2-Magnesiated Oxazoles: A Simple and Efficient Preparation of 2-Acyl Oxazoles." Journal of organic chemistry 72.15 (2007): 5828-5831.
description	9.	Johnson, LN N. "Structural basis for control by phosphorylation." Chemical reviews 101.8 (2001): 2209-2242.
description	10.	Betz, M. "Biomolecular NMR: a chaperone to drug discovery." Current opinion in chemical biology 10.3 (2006): 219-225.
description	11.	Loria, J P P. "A TROSY CPMG sequence for characterizing chemical exchange in large proteins." Journal of biomolecular NMR 15.2 (1999): 151-5.
description	12.	Gallagher, Timothy F. "2,4,5-Triarylimidazole inhibitors of IL-1 biosynthesis." Bioorganic & medicinal chemistry letters 5.11 (1995): 1171-1176.
description	13.	Wilson, K P P. "A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase." Protein science 7.11 (1998): 2249-55.
description	14.	Vial, Nicholas J C. "Structural basis for the interaction of TAK1 kinase with its activating protein TAB1." Journal of molecular biology 354.5 (2005): 1013-20.
description	15.	Felberg, J. "Subdomain X of the kinase domain of Lck binds CD45 and facilitates dephosphorylation." The Journal of biological chemistry 279.5 (2003): 3455-3462.
description	16.	Fejzo, J. "Ajay, MA Murcko and JM Moore." Chemistry & biology 6.101 (1999): 755-.
description	17.	Nagar, B. "Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571)." Cancer research 62.15 (2002): 4236-43.
description	18.	Yamaguchi, H. "Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation." Nature 384.6608 (1996): 484-489.
description	19.	Kumar, S. "Novel homologues of CSBP/p38 MAP kinase: Activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles." Biochemical and biophysical research communications 235.3 (1997): 533-538.
description	20.	Branford, S. "Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis." Blood 102.1 (2003): 276-83.